AL-57

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAL-57
Drug Alias NameAL-57
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLeukocyte adhesion glycoprotein LFA-1 alpha antagonists
TargetsLeukocyte adhesion glycoprotein LFA-1 alpha
Therapy Area/IndicationsInflammationAutoimmune DiseasesMyocardial Reperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Disease Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Disease Institute Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesMyocardial Reperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A